Health Canada drug identification number

DIN 02142074 — TEVA-GEMFIBROZIL 600 MG

TEVA-GEMFIBROZIL is a tablet of Gemfibrozil marketed by TEVA CANADA LIMITED. The full Gemfibrozil monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02142074
Brand name
TEVA-GEMFIBROZIL
Active ingredient
Gemfibrozil
Strength
600 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
TEVA CANADA LIMITED
Health Canada status
MARKETED
Drug class
Fibric acid derivative (fibrate), classified as an antihyperlipidemic agent

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.